Compare ANIP & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | EVTC |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1999 | 2013 |
| Metric | ANIP | EVTC |
|---|---|---|
| Price | $73.27 | $29.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $107.33 | $35.80 |
| AVG Volume (30 Days) | 302.6K | ★ 477.2K |
| Earning Date | 05-11-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 419.23 | 27.17 |
| EPS | ★ 3.32 | 2.20 |
| Revenue | $206,547,000.00 | ★ $453,869,000.00 |
| Revenue This Year | $19.88 | $10.86 |
| Revenue Next Year | $15.77 | $6.78 |
| P/E Ratio | $22.98 | ★ $12.98 |
| Revenue Growth | 2.47 | ★ 11.48 |
| 52 Week Low | $56.71 | $24.95 |
| 52 Week High | $99.50 | $38.56 |
| Indicator | ANIP | EVTC |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 59.17 |
| Support Level | $62.89 | $28.33 |
| Resistance Level | $85.12 | $30.42 |
| Average True Range (ATR) | 2.72 | 1.19 |
| MACD | -0.02 | 0.27 |
| Stochastic Oscillator | 6.29 | 91.31 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.